4.5 Article

High costs of influenza: Direct medical costs of influenza disease in young children

期刊

VACCINE
卷 28, 期 31, 页码 4913-4919

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.05.036

关键词

Children; Medical cost; Influenza

资金

  1. Staat
  2. MedImmune
  3. Merck and Company
  4. GlaxoSmithKlien
  5. CDC

向作者/读者索取更多资源

This study determined direct medical costs for influenza-associated hospitalizations and emergency department (ED) visits. For 3 influenza seasons, children <5 years of age with laboratory-confirmed influenza were identified through population-based surveillance. The mean direct cost per hospitalized child was $5402, with annual cost burden estimated at $44 to $163 million. Factors associated with high-cost hospitalizations included intensive care unit (ICU) admission and having an underlying high-risk condition. The mean medical cost per ED visit was $512, with annual ED cost burden estimated at $62 to $279 million. Implementation of the current vaccination policies will likely reduce the cost burden. (C) 2010 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据